TB-SLP

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTB-SLP

Drug Alias Nametuberculosis specific latency antigen based vaccine (ISA Pharmaceuticals)TB-specific latency antigen based vaccine (ISA Pharmaceuticals)TB-SLP

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIsa Pharmaceuticals Bv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIsa Pharmaceuticals Bv

Active IndicationsN/A

Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A